VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 185 filers reported holding VIKING THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $531,216 | -29.2% | 47,987 | +3.7% | 0.00% | -40.0% |
| Q2 2023 | $750,199 | +635.5% | 46,280 | +36.3% | 0.01% | +400.0% |
| Q1 2022 | $102,000 | -38.9% | 33,963 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $167,000 | -28.9% | 36,354 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $235,000 | +2.2% | 37,441 | -2.3% | 0.00% | 0.0% |
| Q2 2021 | $230,000 | -5.0% | 38,331 | +0.3% | 0.00% | 0.0% |
| Q1 2021 | $242,000 | +12.6% | 38,215 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $215,000 | -5.7% | 38,114 | -2.8% | 0.00% | 0.0% |
| Q3 2020 | $228,000 | -21.1% | 39,207 | -2.2% | 0.00% | 0.0% |
| Q2 2020 | $289,000 | +60.6% | 40,099 | +4.4% | 0.00% | 0.0% |
| Q1 2020 | $180,000 | -44.8% | 38,415 | -5.5% | 0.00% | 0.0% |
| Q4 2019 | $326,000 | +15.6% | 40,634 | -0.8% | 0.00% | 0.0% |
| Q3 2019 | $282,000 | -17.5% | 40,976 | -0.7% | 0.00% | 0.0% |
| Q2 2019 | $342,000 | -11.6% | 41,261 | +5.9% | 0.00% | 0.0% |
| Q1 2019 | $387,000 | +28.1% | 38,958 | -1.3% | 0.00% | 0.0% |
| Q4 2018 | $302,000 | -49.6% | 39,484 | +14.8% | 0.00% | -50.0% |
| Q3 2018 | $599,000 | +122.7% | 34,403 | +21.3% | 0.00% | +100.0% |
| Q2 2018 | $269,000 | – | 28,367 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |